PR Newswire - Formosa Pharmaceuticals Announces Presentation of ...
TAIPEI, May 22, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. announces that its abstract highlighting the differentiated binding profile and preclinical efficacy of TSY-310, a novel bispe...
Read More

ภาษาไทย
English